The FDA is poised to ease access to the overdose antidote, but experts predict limited impact unless the price comes down.
Even over the counter, Narcan may be too costly to reach many drug users
The FDA is poised to ease access to the overdose antidote, but experts predict limited impact unless the price comes down.